REFERENCES

1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-809.

2. Karuntu JS, Almushattat H, Nguyen XT, et al. Syndromic retinitis pigmentosa. Prog Retin Eye Res. 2025;107:101324.

3. Mazzoni F, Safa H, Finnemann SC. Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture. Exp Eye Res. 2014;126:51-60.

4. Bok D. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl. 1993;17:189-95.

5. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845-81.

6. Young RW. The renewal of photoreceptor cell outer segments. J Cell Biol. 1967;33:61-72.

7. LaVail MM. Rod outer segment disk shedding in rat retina: relationship to cyclic lighting. Science. 1976;194:1071-4.

8. Yang S, Yu F, Yang M, et al. CYLD maintains retinal homeostasis by deubiquitinating ENKD1 and promoting the phagocytosis of photoreceptor outer segments. Adv Sci. 2024;11:e2404067.

9. Parmeggiani F. Clinics, epidemiology and genetics of retinitis pigmentosa. Curr Genomics. 2011;12:236-7.

10. Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N. Stem cell transplantation as a progressing treatment for retinitis pigmentosa. Cell Tissue Res. 2022;387:177-205.

11. Musarella MA, Macdonald IM. Current concepts in the treatment of retinitis pigmentosa. J Ophthalmol. 2011;2011:753547.

12. Zarbin M. Cell-based therapy for degenerative retinal disease. Trends Mol Med. 2016;22:115-34.

13. Kurzawa-Akanbi M, Tzoumas N, Corral-Serrano JC, et al. Pluripotent stem cell-derived models of retinal disease: elucidating pathogenesis, evaluating novel treatments, and estimating toxicity. Prog Retin Eye Res. 2024;100:101248.

14. Yu Y, Li L, Lin S, Hu J. Update of application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders. Stem Cell Res Ther. 2022;13:11.

15. Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science. 1997;277:2000-2.

16. Wewetzer K, Kern N, Ebel C, Radtke C, Brandes G. Phagocytosis of O4+ axonal fragments in vitro by p75- neonatal rat olfactory ensheathing cells. Glia. 2005;49:577-87.

17. Su Z, Chen J, Qiu Y, et al. Olfactory ensheathing cells: the primary innate immunocytes in the olfactory pathway to engulf apoptotic olfactory nerve debris. Glia. 2013;61:490-503.

18. Li Y, Zou T, Xue L, Yin ZQ, Huo S, Xu H. TGF-β1 enhances phagocytic removal of neuron debris and neuronal survival by olfactory ensheathing cells via integrin/MFG-E8 signaling pathway. Mol Cell Neurosci. 2017;85:45-56.

19. Jiang Y, Guo J, Tang X, Wang X, Hao D, Yang H. The immunological roles of olfactory ensheathing cells in the treatment of spinal cord injury. Front Immunol. 2022;13:881162.

20. Lan YX, Yang P, Zeng Z, et al. Gene and protein expression profiles of olfactory ensheathing cells from olfactory bulb versus olfactory mucosa. Neural Regen Res. 2022;17:440-9.

21. Li Y, Sauvé Y, Li D, Lund RD, Raisman G. Transplanted olfactory ensheathing cells promote regeneration of cut adult rat optic nerve axons. J Neurosci. 2003;23:7783-8.

22. Andrews MR, Stelzner DJ. Evaluation of olfactory ensheathing and schwann cells after implantation into a dorsal injury of adult rat spinal cord. J Neurotrauma. 2007;24:1773-92.

23. Zhang L, Zhuang X, Chen Y, Xia H. Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model. Cell Transplant. 2019;28:1585-602.

24. Panni P, Ferguson IA, Beacham I, Mackay-Sim A, Ekberg JA, St John JA. Phagocytosis of bacteria by olfactory ensheathing cells and Schwann cells. Neurosci Lett. 2013;539:65-70.

25. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255-89.

26. Luo R, Liu M, Tan T, et al. Emerging significance and therapeutic potential of extracellular vesicles. Int J Biol Sci. 2021;17:2476-86.

27. Kusuma GD, Barabadi M, Tan JL, Morton DAV, Frith JE, Lim R. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front Pharmacol. 2018;9:1199.

28. Zha X. Exosome-based therapy for spinal cord injury: a narrative review. Adv Technol Neurosci. 2025;2:128-34.

29. Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J. Exosomes: new molecular targets of diseases. Acta Pharmacol Sin. 2018;39:501-13.

30. Massoumi H, Amin S, Soleimani M, et al. Extracellular-vesicle-based therapeutics in neuro-ophthalmic disorders. Int J Mol Sci. 2023;24:9006.

31. Yang M, Peng GH. The molecular mechanism of human stem cell-derived extracellular vesicles in retinal repair and regeneration. Stem Cell Res Ther. 2023;14:84.

32. Habiba UE, Greene DL, Ahmad K, Shamim S, Khan N, Umer A. Safety of intravenous mesenchymal stem cell therapy: a meta-analysis of randomized controlled trials. Regen Med Rep. 2025;2:83-99.

33. Fan H, Chen Z, Tang HB, et al. Exosomes derived from olfactory ensheathing cells provided neuroprotection for spinal cord injury by switching the phenotype of macrophages/microglia. Bioeng Transl Med. 2022;7:e10287.

34. Xia B, Gao J, Li S, et al. Extracellular vesicles derived from olfactory ensheathing cells promote peripheral nerve regeneration in rats. Front Cell Neurosci. 2019;13:548.

35. Tu YK, Hsueh YH. Extracellular vesicles isolated from human olfactory ensheathing cells enhance the viability of neural progenitor cells. Neurol Res. 2020;42:959-67.

36. Tu YK, Hsueh YH, Huang HC. Human olfactory ensheathing cell-derived extracellular cesicles: miRNA profile and neuroprotective effect. Curr Neurovasc Res. 2021;18:395-408.

37. Finnemann SC, Bonilha VL, Marmorstein AD, Rodriguez-Boulan E. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proc Natl Acad Sci U S A. 1997;94:12932-7.

38. Finnemann SC, Silverstein RL. Differential roles of CD36 and alphavbeta5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium. J Exp Med. 2001;194:1289-98.

39. Vollrath D, Feng W, Duncan JL, et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci U S A. 2001;98:12584-9.

40. Feng W, Yasumura D, Matthes MT, LaVail MM, Vollrath D. Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells. J Biol Chem. 2002;277:17016-22.

41. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8:327-36.

42. Mantero G, Francia S, Galluzzi F, et al. Phagocytosis by retinal pigment epithelium and microglia does not affect vision restoration by P3HT nanoparticles in Retinitis pigmentosa. Cell Death Dis. 2026;17:295.

43. Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR. AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Mol Ther. 2003;8:188-95.

44. Lew DS, Mazzoni F, Finnemann SC. Microglia inhibition delays retinal degeneration due to MerTK phagocytosis receptor deficiency. Front Immunol. 2020;11:1463.

45. Dowling JE, Sidman RL. Inherited retinal dystrophy in the rat. J Cell Biol. 1962;14:73-109.

46. Carvalho LA, Teng J, Fleming RL, et al. Olfactory ensheathing cells: a Trojan horse for glioma gene therapy. J Natl Cancer Inst. 2019;111:283-91.

47. Sun X, Tan Z, Huang X, et al. Direct neuronal reprogramming of olfactory ensheathing cells for CNS repair. Cell Death Dis. 2019;10:646.

48. Zhang W, McIver AL, Stashko MA, et al. Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. J Med Chem. 2013;56:9693-700.

49. Lu T, Chen L, Mansour AG, et al. Cbl-b is upregulated and plays a negative role in activated human NK cells. J Immunol. 2021;206:677-85.

50. Molday RS, Hicks D, Molday L. Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci. 1987;28:50-61.

51. Bian B, Zhao C, He X, et al. Exosomes derived from neural progenitor cells preserve photoreceptors during retinal degeneration by inactivating microglia. J Extracell Vesicles. 2020;9:1748931.

52. Van Deun J, Mestdagh P, Agostinis P, et al. ; EV-TRACK Consortium. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228-32.

53. A L, Qu L, He J, et al. Exosomes derived from IFNγ-stimulated mesenchymal stem cells protect photoreceptors in RCS rats by restoring immune homeostasis through tsRNAs. Cell Commun Signal. 2024;22:543.

54. Jensen EC. Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec. 2013;296:378-81.

55. Ma J, Chen T, Wu S, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211-7.

56. Chen T, Ma J, Liu Y, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50:D1522-7.

57. Nakamura N, Rabouille C, Watson R, et al. Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol. 1995;131:1715-26.

58. Prasad D, Rothlin CV, Burrola P, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006;33:96-108.

59. Fairn GD, Grinstein S. How nascent phagosomes mature to become phagolysosomes. Trends Immunol. 2012;33:397-405.

60. Nandrot EF, Anand M, Almeida D, Atabai K, Sheppard D, Finnemann SC. Essential role for MFG-E8 as ligand for alphavbeta5 integrin in diurnal retinal phagocytosis. Proc Natl Acad Sci U S A. 2007;104:12005-10.

61. Yang S, Zhou J, Li D. Functions and diseases of the retinal pigment epithelium. Front Pharmacol. 2021;12:727870.

62. Jauregui-Lozano J, Hall H, Stanhope SC, Bakhle K, Marlin MM, Weake VM. The Clock:Cycle complex is a major transcriptional regulator of Drosophila photoreceptors that protects the eye from retinal degeneration and oxidative stress. PLoS Genet. 2022;18:e1010021.

63. Valiente-Soriano FJ, Salinas-Navarro M, Di Pierdomenico J, et al. Tracing the retina to analyze the integrity and phagocytic capacity of the retinal pigment epithelium. Sci Rep. 2020;10:7273.

64. Gao X, Li S, Yang Y, et al. A novel magnetic responsive miR-26a@SPIONs-OECs for spinal cord injury: triggering neural regeneration program and orienting axon guidance in inhibitory astrocytic environment. Adv Sci. 2023;10:e2304487.

65. Chen Z, Fan H, Chen ZY, et al. OECs prevented neuronal cells from apoptosis partially through exosome-derived BDNF. J Mol Neurosci. 2022;72:2497-506.

66. Gal A, Li Y, Thompson DA, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet. 2000;26:270-1.

67. Nandrot E, Dufour EM, Provost AC, et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis. 2000;7:586-99.

68. D’Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9:645-51.

69. Nandrot EF, Silva KE, Scelfo C, Finnemann SC. Retinal pigment epithelial cells use a MerTK-dependent mechanism to limit the phagocytic particle binding activity of αvβ5 integrin. Biol Cell. 2012;104:326-41.

70. Steinberg RH, Wood I, Hogan MJ. Pigment epithelial ensheathment and phagocytosis of extrafoveal cones in human retina. Philos Trans R Soc Lond B Biol Sci. 1977;277:459-74.

71. Mao Y, Finnemann SC. Essential diurnal Rac1 activation during retinal phagocytosis requires αvβ5 integrin but not tyrosine kinases focal adhesion kinase or Mer tyrosine kinase. Mol Biol Cell. 2012;23:1104-14.

72. Umapathy A, Torten G, Paniagua AE, et al. Spatiotemporal live-cell analysis of photoreceptor outer segment membrane ingestion by the retinal pigment epithelium reveals actin-regulated scission. J Neurosci. 2023;43:2653-64.

73. Storm T, Burgoyne T, Futter CE. Membrane trafficking in the retinal pigment epithelium at a glance. J Cell Sci. 2020;133:jcs238279.

74. Gibbs D, Kitamoto J, Williams DS. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc Natl Acad Sci U S A. 2003;100:6481-6.

75. Haines LA, Baeckler AA, Schofield SJ, et al. Non-specific particle formation during extracellular vesicle labelling with the lipophilic membrane dye PKH26. J Extracell Vesicles. 2025;14:e70079.

76. Su X, Zhang S, Zhang T, et al. Glycan-anchored fluorescence labeling of milk-derived extracellular vesicles for investigating their cellular uptake and intracellular fate. Small Methods. 2025;9:e2401996.

77. Andronico LA, Jiang Y, Jung SR, Fujimoto BS, Vojtech L, Chiu DT. Sizing extracellular vesicles using membrane dyes and a single molecule-sensitive flow analyzer. Anal Chem. 2021;93:5897-905.

78. Strohmeier K, Hofmann M, Hauser F, et al. CRISPR/Cas9 genome editing vs. over-expression for fluorescent extracellular vesicle-labeling: a quantitative analysis. Int J Mol Sci. 2021;23:282.

79. Bertolio M, Li Q, Mowry FE, et al. Glutamatergic regulation of miRNA-containing intraluminal vesicle trafficking and extracellular vesicle secretion from cortical neurons. J Extracell Vesicles. 2025;14:e70100.

80. Ablonczy Z, Dahrouj M, Tang PH, et al. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011;52:8614-20.

81. Puddu A, Ravera S, Panfoli I, Bertola N, Maggi D. High glucose impairs expression and activation of MerTK in ARPE-19 cells. Int J Mol Sci. 2022;23:1144.

82. Ramirez MI, Amorim MG, Gadelha C, et al. Technical challenges of working with extracellular vesicles. Nanoscale. 2018;10:881-906.

83. Patel DB, Santoro M, Born LJ, Fisher JP, Jay SM. Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment. Biotechnol Adv. 2018;36:2051-9.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/